The partnership will allow customers using NEBNext Direct target enrichment products to analyze data with the Bluebee platform.
The two companies will work to characterize new Cas nucleases, and NEB will then manufacture and commercially distribute the nucleases globally.
The services will couple NEB's reagents and expertise in enzyme development and manufacturing with TTP's Desktop Biology product development and engineering know-how.
Researchers outlined the "nicking enzyme-assisted sequencing" (NicE-seq) protocol and presented results from proof-of-principal open chromatin profiling experiments.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
The team found that DNA damage affects a variety of samples and may lead to erroneous low-frequency variant calls unless stringent filtering is applied or the damage is repaired prior to sequencing.
The company published the results of an extensive error analysis and plans to use its new high-sensitivity fidelity assay to develop enzymes in the future.
Co-sponsored by Boeing and miniPCR, the winning high school student's project will be carried out by astronauts aboard ISS and is believed to be the first ever PCR in space.
The appeals court agreed with a previous ruling that found New England Biolabs failed to file its lawsuit in a timely manner.
The tool will simplify the design of cloning experiments using the Golden Gate Assembly method, the companies said.
A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.
A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.
Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.
In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.